CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in CNS Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +2 vs. Q4 2025
- Shares held
- 145.6K
- +21.4K (+17.2%) vs. Q4 2025
- Total value
- $348.7K
- −$303.7K (−46.5%) vs. Q4 2025
- New holders
- 4
- 2 more added
- Sold out
- 2
- 0 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 61,000 | $145.8K | 0.13% | +12,173+24.9% | Added |
| Ikarian Capital, LLC | 45,830 | $110.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,189 | $55.7K | 0.00% | +23,189 | New |
| Boothbay Fund Management, LLC | 13,524 | $32.3K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,310 | $3.13K | 0.00% | +1,310 | New |
| UBS Group AG | 729 | $1.74K | 0.00% | +118+19.3% | Added |
| Sound Income Strategies, LLC | 16 | $36 | 0.00% | 00.0% | Unchanged |
| Barrett & Company, Inc. | 8 | $19 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 3 | $8 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $2 | 0.00% | +1 | New |
| Caitong International Asset Management Co., Ltd | 1 | $2 | 0.00% | +1 | New |
| DRW Securities, LLC | 0 | $0 | 0.00% | −15,429−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −4−100.0% | Sold out |